BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Lilly’s Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer’s disease

  September 25, 2025

   · 

  13 min read
• Press Releases

  EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States

  September 25, 2025

   · 

  3 min read
• Press Releases

  Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly

  September 25, 2025

   · 

  13 min read
• Press Releases

  Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology

  September 25, 2025

   · 

  8 min read
• Press Releases

  Zimmer Biomet Announces Japan PMDA Approval of World’s First Iodine-Treated Total Hip Replacement System

  September 25, 2025

   · 

  6 min read
• Press Releases

  Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

  September 25, 2025

   · 

  3 min read
• Press Releases

  Labcorp to Announce Third Quarter Financial Results on October 28, 2025

  September 25, 2025

   · 

  1 min read
• Press Releases

  Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025

  September 25, 2025

   · 

  2 min read
• Press Releases

  ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

  September 25, 2025

   · 

  5 min read
• Press Releases

  Organogenesis Provides Update on Second Phase 3 ReNu® Study

  September 25, 2025

   · 

  6 min read